StonvexLoading…
StonvexStonvexStonvexCore line items from BCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.41B | $1.38B | $5.26B | $3.88B | $2.55B |
Operating Income | Not available | $110.20M | $585.50M | $405.40M | $253.00M |
Net Income | Not available | $32.10M | $199.70M | $131.60M | $95.30M |
EPS (Diluted) | $2.07 | $0.77 | $4.69 | $3.08 | $2.22 |
Total Assets | Not available | $7.28B | $7.34B | $6.95B | $7.09B |
Total Liabilities | Not available | $6.88B | $6.93B | $6.56B | $6.70B |
Cash & Equivalents | Not available | $1.55B | $1.73B | $1.34B | $1.38B |
Free Cash Flow OCF − CapEx | Not available | $-11.40M | $436.40M | $110.50M | $33.10M |
Shares Outstanding | Not available | 41.20M | 41.10M | 41.60M | 41.80M |